| Yi Yen Annie Yeh, MD | |
|
110 Veterans Memorial Blvd Ste 425, Metairie, LA 70005-4959 | |
| (504) 838-8283 | |
| Not Available |
| Full Name | Yi Yen Annie Yeh |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 9 Years |
| Location | 110 Veterans Memorial Blvd Ste 425, Metairie, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235584046 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 321699 (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Administrators Of The Tulane Educational Fund | 0446163760 | 369 |
| Ochsner Clinic Llc | 8224933619 | 2403 |
| Mercy Family Center | 8426296849 | 8 |
News Archive
"Sierra Leone's free health care plan for pregnant women and young children is dysfunctional and hobbled by corruption and a lack of accountability," according to a report released Tuesday by Amnesty International, Agence France-Presse reports.
Texas Breast Specialists, part of Texas Oncology, has expanded its breast cancer treatment services in Dallas, McKinney, Bedford, Carrollton, and Plano, Texas to include the mobile Naviscan PEM scanner.
Forty percent of U.S. adults intend to change their holiday plans due to the risk of being exposed to the H1N1 flu virus, according to a nationwide survey commissioned by JohnsonDiversey, a global leader in the commercial cleaning and sanitizing industry.
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.
Thirty years ago it was rare for a student with ASD to enter college. But over the past decades, there has been much improvement in the detection and awareness of ASD in children.
› Verified 2 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
"Sierra Leone's free health care plan for pregnant women and young children is dysfunctional and hobbled by corruption and a lack of accountability," according to a report released Tuesday by Amnesty International, Agence France-Presse reports.
Texas Breast Specialists, part of Texas Oncology, has expanded its breast cancer treatment services in Dallas, McKinney, Bedford, Carrollton, and Plano, Texas to include the mobile Naviscan PEM scanner.
Forty percent of U.S. adults intend to change their holiday plans due to the risk of being exposed to the H1N1 flu virus, according to a nationwide survey commissioned by JohnsonDiversey, a global leader in the commercial cleaning and sanitizing industry.
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.
Thirty years ago it was rare for a student with ASD to enter college. But over the past decades, there has been much improvement in the detection and awareness of ASD in children.
› Verified 2 days ago
| Entity Name | Administrators Of The Tulane Educational Fund |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528014164 PECOS PAC ID: 0446163760 Enrollment ID: O20031201000636 |
News Archive
"Sierra Leone's free health care plan for pregnant women and young children is dysfunctional and hobbled by corruption and a lack of accountability," according to a report released Tuesday by Amnesty International, Agence France-Presse reports.
Texas Breast Specialists, part of Texas Oncology, has expanded its breast cancer treatment services in Dallas, McKinney, Bedford, Carrollton, and Plano, Texas to include the mobile Naviscan PEM scanner.
Forty percent of U.S. adults intend to change their holiday plans due to the risk of being exposed to the H1N1 flu virus, according to a nationwide survey commissioned by JohnsonDiversey, a global leader in the commercial cleaning and sanitizing industry.
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.
Thirty years ago it was rare for a student with ASD to enter college. But over the past decades, there has been much improvement in the detection and awareness of ASD in children.
› Verified 2 days ago
| Entity Name | Mercy Family Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497895262 PECOS PAC ID: 8426296849 Enrollment ID: O20130524000260 |
News Archive
"Sierra Leone's free health care plan for pregnant women and young children is dysfunctional and hobbled by corruption and a lack of accountability," according to a report released Tuesday by Amnesty International, Agence France-Presse reports.
Texas Breast Specialists, part of Texas Oncology, has expanded its breast cancer treatment services in Dallas, McKinney, Bedford, Carrollton, and Plano, Texas to include the mobile Naviscan PEM scanner.
Forty percent of U.S. adults intend to change their holiday plans due to the risk of being exposed to the H1N1 flu virus, according to a nationwide survey commissioned by JohnsonDiversey, a global leader in the commercial cleaning and sanitizing industry.
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.
Thirty years ago it was rare for a student with ASD to enter college. But over the past decades, there has been much improvement in the detection and awareness of ASD in children.
› Verified 2 days ago
| Entity Name | Womans Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730512906 PECOS PAC ID: 5496984296 Enrollment ID: O20140127000496 |
News Archive
"Sierra Leone's free health care plan for pregnant women and young children is dysfunctional and hobbled by corruption and a lack of accountability," according to a report released Tuesday by Amnesty International, Agence France-Presse reports.
Texas Breast Specialists, part of Texas Oncology, has expanded its breast cancer treatment services in Dallas, McKinney, Bedford, Carrollton, and Plano, Texas to include the mobile Naviscan PEM scanner.
Forty percent of U.S. adults intend to change their holiday plans due to the risk of being exposed to the H1N1 flu virus, according to a nationwide survey commissioned by JohnsonDiversey, a global leader in the commercial cleaning and sanitizing industry.
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.
Thirty years ago it was rare for a student with ASD to enter college. But over the past decades, there has been much improvement in the detection and awareness of ASD in children.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yi Yen Annie Yeh, MD 601 N Carrollton Ave, New Orleans, LA 70119-4700 Ph: (504) 383-5362 | Yi Yen Annie Yeh, MD 110 Veterans Memorial Blvd Ste 425, Metairie, LA 70005-4959 Ph: (504) 838-8283 |
News Archive
"Sierra Leone's free health care plan for pregnant women and young children is dysfunctional and hobbled by corruption and a lack of accountability," according to a report released Tuesday by Amnesty International, Agence France-Presse reports.
Texas Breast Specialists, part of Texas Oncology, has expanded its breast cancer treatment services in Dallas, McKinney, Bedford, Carrollton, and Plano, Texas to include the mobile Naviscan PEM scanner.
Forty percent of U.S. adults intend to change their holiday plans due to the risk of being exposed to the H1N1 flu virus, according to a nationwide survey commissioned by JohnsonDiversey, a global leader in the commercial cleaning and sanitizing industry.
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.
Thirty years ago it was rare for a student with ASD to enter college. But over the past decades, there has been much improvement in the detection and awareness of ASD in children.
› Verified 2 days ago
Dr. Amy Wilcox Voigt, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2905 Kingman St, Metairie, LA 70006 Phone: 504-885-3737 | |
Sydney Smith Melancon, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3901 Houma Blvd Ste 401, Metairie, LA 70006 Phone: 504-889-1448 Fax: 504-885-8752 | |
Donald S Adams, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3800 Houma Blvd, Ste. 205, Metairie, LA 70006 Phone: 504-885-7337 | |
Bennett Onyema Nwankpa, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 222 E Gatehouse Dr, Apt. D, Metairie, LA 70001 Phone: 504-837-4421 Fax: 504-837-4421 | |
Erik Hanson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1219 N Causeway Blvd, Metairie, LA 70001 Phone: 504-800-8235 | |
Dr. Gayle K Stewart, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3350 Ridgelake Drive, Apt 84, Metairie, LA 70002 Phone: 504-895-4817 Fax: 504-309-7845 | |
Dr. Kenneth Boyd Sumner, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3901 Houma Blvd Ste 401, Metairie, LA 70006 Phone: 504-889-1448 Fax: 504-885-8752 |